Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.021x

Based on the latest financial reports, Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) has a cash flow conversion efficiency ratio of -0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-21.56 Million ≈ $-3.15 Million USD) by net assets (CN¥1.03 Billion ≈ $151.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Cheng Du Sheng Nuo Biotec Co. Ltd. A for the company's overall valuation and market capitalisation.

Cheng Du Sheng Nuo Biotec Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Cheng Du Sheng Nuo Biotec Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cheng Du Sheng Nuo Biotec Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cheng Du Sheng Nuo Biotec Co. Ltd. A ranked by their cash flow conversion efficiency. Explore 688117 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Soulbrain Holdings Co. Ltd KQ:036830	0.005x
Gallant Precision Machining Co Ltd TWO:5443	0.001x
Suzhou Alton Electrical & Mechanical Industry Co. Ltd. SHE:301187	-0.070x
WIA Gold Ltd AU:WIA	-0.004x
Vulcan Steel Ltd AU:VSL	0.138x
Guangdong Eastone Century Technology Co Ltd SHE:300310	-0.086x
Beijing Scitop Bio Tech Co Ltd SHE:300858	0.025x
Guaranty Bancshares, Inc. NYSE:GNTY	0.021x

Annual Cash Flow Conversion Efficiency for Cheng Du Sheng Nuo Biotec Co. Ltd. A (2017–2024)

The table below shows the annual cash flow conversion efficiency of Cheng Du Sheng Nuo Biotec Co. Ltd. A from 2017 to 2024. View 688117 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥918.32 Million ≈ $134.38 Million	CN¥25.27 Million ≈ $3.70 Million	0.028x	-72.01%
2023-12-31	CN¥880.10 Million ≈ $128.79 Million	CN¥86.53 Million ≈ $12.66 Million	0.098x	-14.99%
2022-12-31	CN¥826.74 Million ≈ $120.98 Million	CN¥95.62 Million ≈ $13.99 Million	0.116x	+73.26%
2021-12-31	CN¥785.14 Million ≈ $114.89 Million	CN¥52.41 Million ≈ $7.67 Million	0.067x	-63.87%
2020-12-31	CN¥437.57 Million ≈ $64.03 Million	CN¥80.84 Million ≈ $11.83 Million	0.185x	+124.95%
2019-12-31	CN¥376.46 Million ≈ $55.09 Million	CN¥30.92 Million ≈ $4.52 Million	0.082x	-59.40%
2018-12-31	CN¥327.35 Million ≈ $47.90 Million	CN¥66.23 Million ≈ $9.69 Million	0.202x	-16.00%
2017-12-31	CN¥241.74 Million ≈ $35.37 Million	CN¥58.22 Million ≈ $8.52 Million	0.241x	--

About Cheng Du Sheng Nuo Biotec Co. Ltd. A

SHG:688117 China Drug Manufacturers - Specialty & Generic

Market Cap

$553.88 Million

CN¥3.79 Billion CNY

Market Cap Rank

#11823 Global

#3391 in China

Share Price

CN¥24.05

Change (1 day)

+1.35%

52-Week Range

CN¥21.44 - CN¥46.10

All Time High

CN¥48.78